Trial intelligence / Profile preview

AIDSVAX B/E Immune Response Study in Thai Adults

NCT01933685Phase 2Unknown

Sponsor
U.S. Army Medical Research and Development Command
Start
Jul 2014
Primary completion
May 2016
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of AIDSVAX B/E in human immunodeficiency virus infection (HIV), sponsored by U.S. Army Medical Research and Development Command. Status: unknown.

02

Drugs

AIDSVAX B/E
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01933685.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01933685.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call